These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8849605)

  • 41. Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers.
    Cecchetti V; Calderone V; Tabarrini O; Sabatini S; Filipponi E; Testai L; Spogli R; Martinotti E; Fravolini A
    J Med Chem; 2003 Aug; 46(17):3670-9. PubMed ID: 12904071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits.
    Das B; Sarkar C; Karanth KS
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):383-96. PubMed ID: 11692221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An explanation for the reported observation that ATP dependent potassium channel openers mimic preconditioning.
    Downey JM
    Cardiovasc Res; 1993 Sep; 27(9):1565. PubMed ID: 8287432
    [No Abstract]   [Full Text] [Related]  

  • 44. Ischaemic preconditioning and a mitochondrial KATP channel opener both produce cardioprotection accompanied by F1F0-ATPase inhibition in early ischaemia.
    Ala-Rämi A; Ylitalo KV; Hassinen IE
    Basic Res Cardiol; 2003 Jul; 98(4):250-8. PubMed ID: 12835954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperpolarized cardioplegic arrest with nicorandil: advantages over other potassium channel openers.
    Jayawant AM; Lawton JS; Hsia PW; Damiano RJ
    Circulation; 1997 Nov; 96(9 Suppl):II-240-6. PubMed ID: 9386105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology.
    Grover GJ; Garlid KD
    J Mol Cell Cardiol; 2000 Apr; 32(4):677-95. PubMed ID: 10756123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protecting endothelial function: A novel therapeutic target of ATP-sensitive potassium channel openers.
    Minamino T; Hori M
    Cardiovasc Res; 2007 Feb; 73(3):448-9. PubMed ID: 17188255
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of temperature on the activation of myocardial KATP channel in guinea pig ventricular myocytes: a pilot study by whole cell patch clamp recording.
    Jin SQ; Niu LJ; Deng CY; Yao ZB; Zhou YJ
    Chin Med J (Engl); 2006 Oct; 119(20):1721-6. PubMed ID: 17097020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nicorandil for angina.
    Drug Ther Bull; 1995 Dec; 33(12):89-92. PubMed ID: 8777891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic modulation of ATP sensitive potassium channels in ischaemia.
    Cole WC; Aeillo EA
    Cardiovasc Res; 1994 Feb; 28(2):286-7. PubMed ID: 8143315
    [No Abstract]   [Full Text] [Related]  

  • 51. A potassium channel opener as monotherapy in chronic stable angina pectoris: comparison with placebo.
    Why HJ; Richardson PJ
    Eur Heart J; 1993 Jul; 14 Suppl B():25-9. PubMed ID: 8370369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of nicorandil in the treatment of myocardial ischaemia.
    Falase B; Easaw J; Youhana A
    Expert Opin Pharmacother; 2001 May; 2(5):845-56. PubMed ID: 11336627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ATP sensitive potassium channels and ischemic heart disease.
    Gross GJ
    Cardiovasc Res; 1994 Jan; 28(1):139-40. PubMed ID: 8111784
    [No Abstract]   [Full Text] [Related]  

  • 54. Nicorandil attenuates myocardial acidosis during coronary occlusion in dogs.
    Abiko Y; Nishimura T; Sakai K
    Br J Pharmacol; 1984 Feb; 81(2):409-11. PubMed ID: 6231074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of 2,3,4a,11b-tetrahydro-oxazino[2,3-c]benzopyran-9-carbonitriles as ATP-sensitive potassium channel openers.
    Cheng CY; Chiu HI; Chang MJ; Lin YC; Tsai MC; Yu HC
    Bioorg Med Chem Lett; 1998 Mar; 8(5):463-8. PubMed ID: 9871599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardioselective anti-ischemic ATP-sensitive potassium channel openers. 3. Structure-activity studies on benzopyranyl cyanoguanidines: modification of the cyanoguanidine portion.
    Atwal KS; Grover GJ; Ahmed SZ; Sleph PG; Dzwonczyk S; Baird AJ; Normandin DE
    J Med Chem; 1995 Aug; 38(17):3236-45. PubMed ID: 7650676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A symposium: A new treatment for angina pectoris and heart failure. October 17, 1987, San Francisco. Proceedings.
    Am J Cardiol; 1989 Jun; 63(21):1J-85J. PubMed ID: 2525318
    [No Abstract]   [Full Text] [Related]  

  • 58. A multicenter comparison of nicorandil and diltiazem on serum lipid, apolipoprotein, and lipoprotein levels in patients with ischemic heart disease.
    Sasaki J; Saeki Y; Kawasaki K; Umeno M; Ikeda K; Handa K; Arakawa K
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):471-4. PubMed ID: 1450091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
    Coghlan MJ; Carroll WA; Gopalakrishnan M
    J Med Chem; 2001 May; 44(11):1627-53. PubMed ID: 11356099
    [No Abstract]   [Full Text] [Related]  

  • 60. Gating mechanisms of ATP sensitive potassium channels: implication in reperfusion injury and preconditioning.
    Lee CY
    Cardiovasc Res; 1994 Jun; 28(6):729-34. PubMed ID: 7923271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.